By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
India Times NowIndia Times NowIndia Times Now
Notification Show More
Font ResizerAa
  • Bharat Shreshtha Ratna Sanman
  • India News
  • Categories
    • Technology
    • Entertainment
    • The Escapist
    • Insider
    • Finance ₹
    • India News
    • Science
    • Health
Reading: Pharma stock on investors’ radar as net profit jumps 93%, board approves NSE listing proposal
Share
India Times NowIndia Times Now
Font ResizerAa
  • Bharat Shreshtha Ratna Sanman
  • India News
  • Categories
Search
  • Bharat Shreshtha Ratna Sanman
  • India News
  • Categories
    • Technology
    • Entertainment
    • The Escapist
    • Insider
    • Finance ₹
    • India News
    • Science
    • Health
Have an existing account? Sign In
Follow US

Home » Pharma stock on investors’ radar as net profit jumps 93%, board approves NSE listing proposal

BusinessStartup

Pharma stock on investors’ radar as net profit jumps 93%, board approves NSE listing proposal

India Times Now Desk
Last updated: November 6, 2026 9:56 am
India Times Now Desk
Published: November 6, 2026
Share
SHARE


Shares of pharma company Fredun Pharmaceuticals will be on investors’ radar after the company informed exchanges that its board approved a proposal to list its equity shares on the National Stock Exchange of India (NSE). The pharmaceutical and healthcare company has also announced its financial results for the second quarter and half-year ended September 30, 2026. It posted a robust 93.4 per cent year-on-year (YoY) increase in standalone net profit.

Q2 revenue of the company 

The company’s consolidated revenue from operations surged 85.15 per cent YoY to Rs 265.85 crore for the July–September 2026 quarter, compared to Rs 143.59 crore in the corresponding quarter of the previous fiscal year. On a sequential basis, revenue grew 16.7 per cent from Rs 227.76 crore in Q1 FY27. 

According to the information shared with exchanges, its net profit for the quarter under review stood at Rs 18.83 crore, up 93.44 per cent YoY from Rs 9.73 crore reported in Q2 FY26 and up 42.97 per cent QoQ from Rs 13.17 crore in Q1 FY27.   

For the six-month period ended September 30, 2026, standalone net revenue almost doubled to Rs 493.61 crore from Rs 262.99 crore in H1 FY26. The net profit of the company for H1 FY27 rose to Rs 31.99 crore from Rs 16.50 crore in the year-ago period.

Key Highlights of the results 

Financial Metric / Particular

Q2 FY27 (Rs in Crore)

Q2 FY26 (Rs in Crore)

YoY Growth / Change

Net Revenue from Operations (Standalone)

Rs 265.85

Rs 143.59

+85.15%

Total Income (Standalone)

Rs 267.63

Rs 145.29

+84.20%

Profit Before Tax (PBT)

Rs 29.90

Rs 13.01

+129.82%

Net Profit / PAT (Standalone)

Rs 18.83

Rs 9.73

+93.44%

Net Profit / PAT (Consolidated)

Rs 18.57

Rs 9.43

+96.92%

Basic Earnings Per Share (EPS)

Rs 11.21

Rs 6.87

+63.17%

 

Stock price today 

The counter opened in the green at Rs 1,504.90, up Rs 11.45 from the previous close of Rs 1,493.45 on the BSE. It gained further to Rs 1,505.45, before witnessing profit booking and fell to touch the intraday low of Rs 1,424, representing a drop of Rs 69.45 or 4.65 per cent. 

Last seen, the stock was trading at Rs 1,431.05 with a drop of Rs 62.40 or 4.18 per cent, and the market cap of the company stood at Rs 2,366.68 crore. 

Share price history

According to BSE Analytics, the stock has given strong returns of 757 per cent in five years and 403.57 per cent in three years. On a year-to-date (YTD) basis, it has gained 183.44 per cent, compared with the correction of 5.32 per cent in the benchmark index. 

ALSO READ:

 

Hidden cost of investing: Are investors losing returns without realising it? Find out here

(This article is for informational purposes only and should not be construed as investment, financial, or other advice.)





Source link

132% return in 1 year: Company plans expansion in FMCG, power and energy sector – Check share price
Jio Platforms IPO anchor book: From Wall Street giants to domestic titans, heavyweights lead the charge
Market Opening Bell: Sensex opens in red, Nifty near 26,000 ahead of RBI MPC announcement
BSE smallcap stock gains as company set to raise funds via foreign currency convertible bonds: Details
TCS Quarterly Results: IT stock in focus ahead of Q4 results today, may declare final dividend – Details
TAGGED:approvesboardInvestorsjumpslistingnetnsepharmaprofitproposalradarstockstock in focus
Share This Article
Facebook Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe
TelegramFollow

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
[mc4wp_form]
Popular News

‘Bloody Romeo’: Nani-Sujeeth film gets a title

India Times Now Desk
India Times Now Desk
February 24, 2026
Delhi Metro: Government approves 7 new corridors costing Rs 48,204.56 crore
PM SHRI Kendriya Vidyalaya in Macherla to start classes for 2026-27 from Government Boys High School campus
Car plunges into river while trying to avoid hitting wild boar; youths have miraculous escape
A.P. BJP chief conducts Janata Varadhi at NTR Collectorate
- Advertisement -
Ad imageAd image
Global Coronavirus Cases

Confirmed

0

Death

0

More Information:Covid-19 Statistics
© INDIA TIMES NOW 2026 . All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?